SOPHiA Genetics SA
SOPHiA Genetics SA (SOPH) Covered Calls
As of September 25, 2026, SOPH has 2 covered call opportunities in the coming three months. Return ranges from 21.1 to 28.3% until expiration. Annualized return ranges from 59.0 to 91.7%. The nearest expiration is December 18, 2026. Maximum potential profit is $236.
Read more
Running SOPH covered calls helps you generate consistent income from SOPHiA Genetics SA's shares you already own, turning a long stock position into a yield-producing asset. A covered call on SOPHiA Genetics SA involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best SOPH covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if SOPH stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling SOPH covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given SOPHiA Genetics SA covered call is worth writing.
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Income-focused investors, long-term SOPH holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling SOPH covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best SOPHiA Genetics SA covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryHealth Information Services
- SectorHealthcare
- IV percentile4.37% Subdued
- Market cap (M$)710
- 52 weeks high-7.13%
- 52 weeks low144.57%
- Analyst recommendationStrong Buy
1.00 - Target price$9.75
16.91% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E—
- EPS (ttm)-1.15
- EPS growth next 5 years32.33%
As of September 25, 2026
| 2026-12-18 | 84 | 10.00 | 19.90 | 0.10 | 0.55 | 176.00 | 21.10 | 91.70 | -1.20 | +0.28 | 1,412 | 0.45 |
| 2027-03-19 | 175 | 10.00 | 19.90 | 0.70 | 2.15 | 236.00 | 28.30 | 59.02 | -8.39 | +0.51 | 128 | 1.45 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best SOPH covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→